- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02013518
Cognitive Behavioural Therapy for Persons With MCI or Mild Dementia
Cognitive Behavioural Therapy for Persons With Mild Cognitive Impairment or Dementia in the Early Stages
A total of 200 home dwelling participants, who fulfil the inclusion criteria, Alzheimer's disease, will be recruited from three hospitals in Norway.
The intervention is based on a standardized manual, and consists of 11 weekly one-hour sessions, which are organized into six thematic modules.
The content of each session is specified by a treatment manual, which additionally consists of worksheets, suggestions for homework in between sessions and letters to the caregivers (the German manual: Werheid & Thöne-Otto, 2010; the Norwegian manual: Ulstein, Gordner & Tonga, not published). The treatment will be conducted by experienced health staff (nurses, psychologist, doctors) with formal training in Cognitive Behavioural Therapy, and knowledge about Alzheimer's Disease. Furthermore, the health staff will be familiarised with the manual before study inception, participate in a two-day training seminar and will regularly be supervised.
The control condition will be offered treatment as usual at the participating the memory clinics.
The hypothesis is that the participants in the intervention group will report less depression and increased self efficacy as compared with the control group.
We conducted a pilot study with 10 patients, 5 in each group, from March to June 2013 to examine the feasibility of the study protocol and do want to include these patients in the study population.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Oslo, Norway
- Oslo University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
A diagnosis of dementia (Alzheimers disease or mixed Alzheimer and vascular dementia) within the past twelve months, consistent with the ICD-10.
Mini Mental Examination score of twenty or above Cornell Depression Scale score of five or above A career who is willing to participate in the interventions, as this is part of the treatment programme. A carer is here defined as the main person responsible for the informal care for the patient and who has regular weekly contact with the patient.
Exclusion Criteria:
Severe somatic or psychiatric comorbid diagnoses, including alcohol and substance abuse, that would impair their cooperation in the intervention programme Dementia with Lewy bodies and frontotemporal dementia, as the intervention is considered to be too cognitively challenging for these patients Poor command of Norwegian Ongoing psychotherapy
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cognitive behavioural therapy
11 standardised weekly one-hour sessions/6 modules: Module one - introduction to the programme.
Module two - pleasant activities to improve mood and depressive symptoms.
Module three - the use of external memory aids to help the patients to maintain independence in their daily life.
Module four - establishing behavioural routines to reduce demands on memory.
Module five - stimulates patients to actively engage in reminiscence and memories to improve mood and well-being.
Module six - review of the programme and individual treatment goals.
|
11 standardised weekly one-hour sessions/6 modules: Module one - introduction to the programme.
Module two - pleasant activities to improve mood and depressive symptoms.
Module three - the use of external memory aids to help the patients to maintain independence in their daily life.
Module four - establishing behavioural routines to reduce demands on memory.
Module five - stimulates patients to actively engage in reminiscence and memories to improve mood and well-being.
Module six - review of the programme and individual treatment goals.
|
|
Other: Control group
Treatment as usual at the participating memory clinics
|
11 standardised weekly one-hour sessions/6 modules: Module one - introduction to the programme.
Module two - pleasant activities to improve mood and depressive symptoms.
Module three - the use of external memory aids to help the patients to maintain independence in their daily life.
Module four - establishing behavioural routines to reduce demands on memory.
Module five - stimulates patients to actively engage in reminiscence and memories to improve mood and well-being.
Module six - review of the programme and individual treatment goals.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants reporting decrease in depression scores
Time Frame: Up to nine month
|
Depression, measured by the Montegomery and Åsberg Depression Rating Scale (MADRS) (Åsberg et al., 1978), the Hospital Anxiety and Depression Scale (HAD) (Zigmond & Snaith, 1983) and the Cornell Scale for Depression in Dementia (Alexopoulos, Abrams, Young & Shamoian, 1988).
In addition MADRS will be used to measure depression in the carers.
|
Up to nine month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants reporting increased Self-efficacy
Time Frame: Up to 9 month
|
Self Efficacy, measured by Generalized Self-Efficacy Scale (Sherer et al., 1982) will be measured in the patients and carers.
|
Up to 9 month
|
|
Number of participants reporting increased Quality of Life
Time Frame: Up to 9 month
|
Quality of life, measured by the Quality of Life in Alzheimer's Disease (QOL-AD) (Logdson et al., 1999)will be measured in the patients and carers.
|
Up to 9 month
|
|
Number of participants reporting change in cognitive function
Time Frame: Up to 9 month
|
Neuropsychological tests, such as Mini Mental state examination (MMSE), Trial Making Test (TMTA and TKTB) and CERAD 10-word test, will be conducted.
This test is widely used to evaluate the cognitive impairments required for the AD diagnoses.
|
Up to 9 month
|
|
Number of participating caregivers reporting decreased burden of care
Time Frame: 3 month and 9 month
|
Overall burden in the carers, measured by The Relatives' Stress Scale (RSS) (Greene, Smith, Gardiner & Timbury, 1982).
|
3 month and 9 month
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants reporting satisfaction with the intervention programme
Time Frame: Up to 9 month
|
Client Satisfaction Scale (CSQ-8) (Larsen, Attkisson & Ngyen, 1979) (patient rated).
|
Up to 9 month
|
|
Number of participants with a decreased number and severity of neuropsychiatric symptoms
Time Frame: Up to 9 month
|
The Neuropsychiatric Inventory Questionnaire (NPI-Q) (Cummings et al., 1997) (proxy rated)
|
Up to 9 month
|
|
Use and costs of health care services
Time Frame: Up to 9 month
|
The Resource Utilisation in Dementia (RUD Lite) (Wimo, 1998) (patient rated), and client satisfaction measured by
|
Up to 9 month
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Ingun D Ulstein, MD PhD, Old Age Psychiatric Department, Oslo Univeristy Hospital, slottsberget 35, 1385 Asker, Norway
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2012/1943
- 12345 (Danish Center for Healthcare Improvements)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alzheimers' Disease
-
Washington University School of MedicineNational Institute on Aging (NIA); Alzheimer's Association; Eisai Inc.; Accelerating...Active, not recruitingDementia | Alzheimers Disease | Alzheimers Disease, FamilialUnited States, Canada, France, Spain, Brazil, Italy, Ireland, Argentina, Australia, Colombia, Netherlands, Puerto Rico, United Kingdom, Germany, Japan, Mexico
-
Washington University School of MedicineEli Lilly and Company; Hoffmann-La Roche; Avid Radiopharmaceuticals; National Institute... and other collaboratorsActive, not recruitingDementia | Alzheimers Disease | Alzheimers Disease, FamilialUnited States, Canada, France, Spain, Brazil, Italy, Ireland, Argentina, Australia, Colombia, Netherlands, Puerto Rico, United Kingdom, Japan, Germany
-
Washington University School of MedicineHoffmann-La Roche; National Institute on Aging (NIA); Alzheimer's AssociationTerminatedDementia | Alzheimers Disease | Alzheimers Disease, FamilialUnited States, Spain, France, Australia, Puerto Rico, United Kingdom
-
Washington University School of MedicineEli Lilly and Company; Hoffmann-La Roche; Avid Radiopharmaceuticals; National Institute... and other collaboratorsCompletedDementia | Alzheimers Disease | Alzheimers Disease, FamilialUnited States, Canada, France, Spain, Ireland, Australia, Puerto Rico, United Kingdom
-
Washington University School of MedicineEli Lilly and Company; National Institute on Aging (NIA); Alzheimer's AssociationRecruitingDementia | Alzheimers Disease | Alzheimers Disease, FamilialUnited States, Canada, Argentina, Australia, Colombia, Italy, Puerto Rico, United Kingdom, France, Netherlands, Spain, New Zealand, Germany, Mexico
-
Washington University School of MedicineEli Lilly and Company; National Institute on Aging (NIA); Alzheimer's Association and other collaboratorsRecruitingDementia | Alzheimers Disease | Alzheimers Disease, FamilialUnited States, Canada, Argentina, Australia, Colombia, Italy, Puerto Rico, United Kingdom, France, Netherlands, Spain, New Zealand, Germany, Mexico
-
Northwestern UniversityPatient-Centered Outcomes Research InstituteCompletedAlzheimers, Falls, Aging in PlaceUnited States
-
Halia Therapeutics, Inc.Not yet recruitingAlzheimers DiseaseUnited Arab Emirates
-
Neurology Office of South FloridaBristol-Myers SquibbNot yet recruiting
-
Banner HealthNational Institute on Aging (NIA); Universidad de AntioquiaNot yet recruitingAlzheimers Disease | Early Onset Alzheimer Disease | Autosomal Dominant Alzheimers DiseaseColombia
Clinical Trials on Cognitive Behavioural Therapy
-
Lawson Health Research InstituteUniversity of Western Ontario, CanadaRecruiting
-
University of AberdeenCompleted
-
Mental Health Services in the Capital Region, DenmarkCentral Denmark Region; Mental Health Services in the North Denmark RegionCompletedPsychotic Disorders | Schizophrenia and Related Disorders | Schizotypal Disorder | Schizophrenia Prodromal | Paranoid Schizophrenia | Paranoid Ideation | Paranoid Delusion | Ideas of Reference | Psychosis Paranoid | Psychotic Paranoia | Psychotic; Disorder, DelusionalDenmark
-
Mental Health Services in the Capital Region, DenmarkUniversity of CopenhagenCompletedPosttraumatic Stress DisorderDenmark
-
Solent NHS TrustUniversity of Oxford; Talking Change (Solent NHS Trust); Constable & RobinsonCompletedSocial Anxiety Disorder | Cognitive Behavioral Therapy | BibliotherapyUnited Kingdom
-
Linkoeping UniversityCompletedAdjustment DisordersSweden
-
University of BergenCompleted
-
Centre for Addiction and Mental HealthCompleted
-
Chinese University of Hong KongRecruitingDiabetes Mellitus, Type 2 | InsomniaHong Kong
-
Nova Scotia Health AuthorityCanadian Institutes of Health Research (CIHR); Dalhousie University; University...CompletedMajor Depression | Social Anxiety | Panic Disorder | Generalized Anxiety | Stress Disorder, Posttraumatic